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YEAR IN CARDIOLOGY SERIES YEAR IN CARDIOLOGY SERIES1645Clinical Cardiac ElectrophysiologyGregory M. Marcus, Melvin M. Scheinman, Edmund Keung
Marcus and colleagues review the past year’s literature and summarize key papers in the field
of electrophysiology. A large portion of the review is devoted to atrial fibrillation, in which
recent papers have shown the noninferiority of lenient rate control and the efficacy of
alternatives to warfarin, leading to changes in guidelines reflecting these and other recent
publications.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY
1656Proximal Occlusion May Reduce Risk of CVA
During Carotid Stenting Compared With FilterWirePiero Montorsi, Luigi Caputi, Stefano Galli, Elisa Ciceri, Giovanni Ballerini, Marco Agrifoglio,
Paolo Ravagnani, Daniela Trabattoni, Gianluca Pontone, Franco Fabbiocchi, Alessandro Loaldi,
Eugenio Parati, Daniele Andreini, Fabrizio Veglia, Antonio L. Bartorelli
Montorsi and colleagues compared the rate of cerebral microembolization during carotid
artery stenting (CAS) with proximal compared with distal cerebral protection. Subjects were
randomized to CAS with proximal (MO.MA system, Invatec, Roncadelle, Brescia, Italy) or
distal protection with a filter (FilterWire EZ, Boston Scientific Corporation, Santa Clara,
California). The MO.MA system occludes flow in the internal carotid artery for the
procedure, and then blood, presumably containing any potential sources of emboli, is
withdrawn from the stented area and discarded prior to restoring flow. Compared with the
FilterWire EZ, MO.MA significantly reduced the number of microembolic signals detected
with transcranial Doppler. There was also a strong, but nonsignificant, reduction in the rate
of new post-CAS embolic lesions detected on magnetic resonance imaging scans (14%
MO.MA vs. 43% FilterWire EZ). In patients undergoing CAS, proximal vessel occlusion
may be superior to distal vessel filtering.(continued on page A-27)
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1664Statins Appear to Be Beneficial in Post-AMI Patients,
Even if Baseline LDL-C Is <70 mg/dlKi Hong Lee, Myung Ho Jeong, Ha Mi Kim, Youngkeun Ahn, Jong Hyun Kim, Shung Chull Chae,
Young Jo Kim, Seung Ho Hur, In Whan Seong, Taek Jong Hong, Dong Hoon Choi,
Myeong Chan Cho, Chong Jin Kim, Ki Bae Seung, Wook Sung Chung, Yang Soo Jang,
Seung Woon Rha, Jang Ho Bae, Jeong Gwan Cho, Seung Jung Park, for the KAMIR
(Korea Acute Myocardial Infarction Registry) Investigators
Lee and colleagues reviewed data collected from the KAMIR (Korea Acute Myocardial
Infarction Registry) to explore the utility of prescribing statins to patients with acute
myocardial infarction (AMI) who have baseline low-density lipoprotein cholesterol (LDL-C)
levels 70 mg/dl. The 1,500 AMI survivors with baseline LDL-C 70 mg/dl were divided
into groups based on whether they were prescribed a statin at discharge. Statin therapy
significantly reduced the risk of the composite primary endpoint by approximately one-half
and also significantly reduced the individual endpoints of cardiac death and coronary
revascularization. These results suggest that a statin medication should be prescribed to all
survivors of an AMI, regardless of baseline LDL-C levels.Editorial Comment: John C. LaRosa, p. 1672CARDIOVASCULAR RISK1674Higher Testosterone Levels Associated With Lower Cardiovascular RiskClaes Ohlsson, Elizabeth Barrett-Connor, Shalender Bhasin, Eric Orwoll, Fernand Labrie,
Magnus K. Karlsson, Östen Ljunggren, Liesbeth Vandenput, Dan Mellström, Åsa Tivesten
Low serum testosterone is associated with increased adiposity and an adverse metabolic risk
profile, but it is less clear whether high endogenous testosterone levels are protective. Ohlsson
and colleagues analyzed baseline levels of testosterone from a prospective population-based
study (2,416 men, age 69 to 81 years). During a median 5-year follow-up, total testosterone
levels were inversely associated with cardiovascular (CV) risk. Men in the highest quartile
(550 ng/dl) had lower risk, and the association remained significant after adjustment for
traditional CV risk factors.(continued on page A-31)
OCTOBER 11, 2011 (continued) A-31CARDIAC RESYNCHRONIZATION THERAPY1682Left Atrial Reverse Remodeling With CRT-D Lowers Risk of Atrial ArrhythmiasAndrew Brenyo, Mark S. Link, Alon Barsheshet, Arthur J. Moss, Wojciech Zareba, Paul J. Wang,
Scott McNitt, David Huang, Elyse Foster, Mark Estes III, Scott D. Solomon, Ilan Goldenberg
Brenyo and colleagues hypothesized that reductions in left atrial volume (LAV) with cardiac
resynchronization therapy would translate into a subsequent reduction in the risk of atrial
tachyarrhythmias (ATs). They used data from MADIT-CRT (Multicenter Automatic
Defibrillator Implantation Trial with Cardiac Resynchronization Therapy), in which subjects
were randomized to either cardiac resynchronization therapy with defibrillator (CRT-D) or a
standard implantable cardioverter-defibrillator (ICD). Left atrial remodeling was defined as a
20% reduction in LAV between enrollment and 1-year echocardiogram. The cumulative
probability of any AT from years 1 to 3.5 was 3% in LAV responders, compared with 9% in
nonresponders and 7% in the ICD-only arm. This study demonstrates that CRT-D results in
substantial reverse remodeling of the left atrium in some subjects and can reduce the
subsequent risk of atrial fibrillation and atrial flutter by one-half.CARDIAC IMAGING
1690Cost-Effectiveness of Screening Asymptomatic Individuals
With Coronary Artery Calcium ScanningBob J. H. van Kempen, Sandra Spronk, Michael T. Koller, Suzette E. Elias-Smale, Kirsten E. Fleischmann,
M. Arfan Ikram, Gabriel P. Krestin, Albert Hofman, Jacqueline C. M. Witteman, M. G. Myriam Hunink
van Kempen and colleagues developed a Markov Model to assess the cost-effectiveness of
screening asymptomatic individuals at intermediate risk of coronary heart disease (CHD) for
coronary artery calcium with computed tomography (CT). Four strategies were evaluated:
1) current practice; 2) current prevention guidelines for cardiovascular disease;
3) CT screening for coronary calcium; and 4) statin therapy for all individuals. In men,
CT screening was more effective and more costly than the other 3 strategies, with an
incremental cost-effectiveness ratio of $48,800 per quality-adjusted life year gained. In
women, CT screening was more effective and more costly than current practice, but was
less effective than implementing current guidelines in all women. Screening for coronary
artery calcium with CT in individuals at intermediate risk of CHD may be cost-effective
in men, but is unlikely to be cost-effective in women.
Editorial Comment: Philip Greenland, Tamar S. Polonsky, p. 1702(continued on page A-32)
OCTOBER 11, 2011 (continued) A-32BIOMARKERS IN VALVE DISEASE1705BNP May Be a Useful Biomarker for Patients With Severe Aortic InsufficiencyRodolfo Pizarro, Oscar O. Bazzino, Pablo F. Oberti, Mariano L. Falconi, Anı´bal M. Arias,
Juan G. Krauss, Arturo M. Cagide
Pizarro and colleagues sought to determine the prognostic value of measuring brain natriuretic
peptide (BNP) levels in patients with severe asymptomatic aortic regurgitation and normal left
ventricular function. The combined endpoint was the occurrence of symptoms of congestive
heart failure, left ventricular dysfunction, or death. An optimal cut-off point of 130 pg/ml for
BNP was able to discriminate patients at higher risk. BNP was the strongest independent
predictor by multivariate analysis. Measuring BNP may help to identify patients with severe
asymptomatic aortic regurgitation who are at higher risk for adverse events and who may
benefit from earlier intervention.PRE-CLINICAL RESEARCH PRE-CLINICAL RESEARCH1715Blocking Macrophage Uptake of Oxidized LDL Prevents AtherosclerosisSotirios Tsimikas, Atsushi Miyanohara, Karsten Hartvigsen, Esther Merki, Peter X. Shaw, Meng-Yun Chou,
Jennifer Pattison, Michael Torzewski, Janina Sollors, Theodore Friedmann, N. Chin Lai, H. Kirk Hammond,
Godfrey S. Getz, Catherine A. Reardon, Andrew C. Li, Carole L. Banka, Joseph L. Witztum
Tsimikas and colleagues have been studying the importance of scavenger receptor (SR)-
mediated uptake of oxidized low-density lipoprotein (OxLDL) in atherosclerosis. Cholesterol-
fed low-density lipoprotein receptor knockout mice were treated with intraperitoneal infusion
of human IK17-Fab, which binds to OxLDL and prevents its uptake by macrophages, but
lacks the immunological properties of intact antibodies. Infusion of IK17-Fab produced a
29% reduction in the extent of aortic atherosclerosis, but the mice then developed antibodies
to the protein. A second model, which used gene transfer to stimulate endogenous production
of the antibody, led to a 46% reduction in en face atherosclerosis compared with placebo as
well as decreased lipid content in macrophages retrieved from the peritoneum. These data
support an important role for SR-mediated uptake of OxLDL in the pathogenesis of
atherosclerosis.
